Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Asker Healthcare Group AB operates in the healthcare industry, focusing on providing medical supplies, services, and equipment primarily to healthcare institutions. The company is involved in the distribution and logistics of medical consumables and advanced medical technology products. Headquartered in Sweden, Asker Healthcare Group serves markets across Europe, leveraging its extensive network to cater to hospitals, care homes, and other healthcare service providers. The company emphasizes efficient supply chain management and aims to support healthcare professionals with reliable product accessibility and quality service, ensuring continuity in patient care.
View stock
VS
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
View stock

Stock highlights

Stock comparison highlights
Stock name
Asker Healthcare Group ABAbbVie
Last price
kr 71.15$294.89
Currency
SEK
USD
kr 27B$521B
38.1250.77
kr 1.87$5.81
--
kr 0.39$6.83
0.55%2.35%
Sector
HealthHealth
Employees
4,88557,000
Ticker
Skr ASKER$ABBV
Primary listing
XSTONYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in SkrASKER or $ABBV on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.